Dual antiplatelet therapy in patients with cirrhosis and acute myocardial infarction - A 13-year nationwide cohort study.

Victor Chien-Chia WuShao-Wei ChenAn-Hsun ChouPei-Chi TingChih-Hsiang ChangMichael WuMing-Jer HsiehChao-Yung WangShang-Hung ChangMing-Shyan LinKuo-Chun HungI-Chang HsiehPao-Hsien ChuCheng-Shyong WuYu-Sheng Lin

Published in: PloS one (2019)

In cirrhotic patients with AMI, DAPT offers benefit with decreased recurrent MI at the expense of increased gastrointestinal bleeding.

Keyphrases

antiplatelet therapy
acute myocardial infarction
percutaneous coronary intervention
acute coronary syndrome
coronary artery disease
atrial fibrillation
cross sectional
left ventricular
heart failure